ADCs
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
67
NCT06805825
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 3, 2025
Completion: Dec 31, 2027
Loading map...